Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
New York City stands out as a location known for a diverse array of clinical trials, thanks to its extensive healthcare network and renowned medical research institutions. Leading centers such as Memorial Sloan Kettering Cancer Center, NYU Langone Health, Mount Sinai Health System, and Weill Cornell Medicine are at the forefront of pioneering studies across various fields. The city's rich combination of cutting-edge research facilities and a diverse population enhances the scope and impact of clinical trials conducted here.
Want a closer look at research in New York? Read our guide: Clinical Trials in NYC: Where the Studies Are
Why choose New York City for clinical trials?
New York City is an exceptional choice for participating in clinical trials, renowned for its innovative research environment and strong emphasis on groundbreaking medical advancements, with prestigious institutions such as Memorial Sloan Kettering Cancer Center, NYU Langone Health, and Mount Sinai Health System at the forefront.
By participating in a clinical trial in New York City, you not only gain early access to cutting-edge treatments but also contribute to significant medical research that could shape future healthcare practices.
Common conditions studied in New York City
In New York City, clinical trials focus on a wide range of medical conditions and diseases, leveraging the city's renowned research institutions and diverse patient population.
Infectious Diseases
New York City’s expertise in infectious disease research is exemplified by ongoing trials on HIV/AIDS, hepatitis, and emerging infectious diseases. Institutions like NYU Langone Health and Weill Cornell Medicine are involved in studies that test new antiviral drugs, vaccines, and treatment regimens aimed at controlling and eventually curing these diseases. The city’s experience with global health challenges also supports research on responses to new and emerging infections.
Neurological disorders
Clinical research in New York City covers a broad spectrum of neurological conditions. Trials at NYU Langone Health and Mount Sinai Health System explore new treatments and interventions for Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis (MS). These studies include investigations into disease-modifying therapies, novel drug candidates, and advanced diagnostic tools aimed at improving early detection and personalized treatment approaches.
Cardiovascular diseases
The city’s clinical trials also address various cardiovascular diseases, such as coronary artery disease, heart failure, and hypertension. The Icahn School of Medicine at Mount Sinai conducts research on cutting-edge treatments, including advanced cardiac devices, innovative drug therapies, and lifestyle interventions designed to improve cardiovascular health and prevent heart disease.
Metabolic and endocrine disorders
Clinical trials in New York City focus on various metabolic and endocrine disorders, including diabetes and thyroid diseases. Research centers here work on developing better management strategies and innovative treatments for diabetes, exploring new medications, and studying lifestyle interventions that could improve patient outcomes. Trials also investigate treatments for thyroid disorders, aiming to enhance diagnostic accuracy and therapeutic effectiveness.
Autoimmune diseases
Trials investigating autoimmune diseases such as lupus, rheumatoid arthritis, and Crohn’s disease are prevalent in New York City. Institutions like Memorial Sloan Kettering Cancer Center and NYU Langone Health explore new therapies that target the underlying immune dysfunction driving these conditions. Research often includes studies on biologics, small molecules, and combination therapies aimed at reducing inflammation and improving quality of life for patients.
Cancer
New York City is a leading center for oncology research, with numerous clinical trials investigating a range of cancers. Memorial Sloan Kettering Cancer Center, a world-renowned institution, conducts trials on innovative treatments for leukemia, breast cancer, lung cancer, and prostate cancer, among others.
Trials often focus on developing targeted therapies that specifically attack cancer cells, immunotherapies that harness the body’s immune system to fight cancer, and novel combination therapies designed to enhance treatment efficacy and minimize resistance.
Interested in learning more about how clinical trials for cancer work? Explore our guide to better understand oncology clinical trials and how they contribute to advancing cancer treatments.
Local regulations and guidelines
In New York City, clinical trials are governed by stringent regulations to ensure participant safety and research integrity. The primary regulatory body is the U.S. Food and Drug Administration (FDA), which sets national standards for clinical trials, including Good Clinical Practice (GCP) guidelines. In addition to federal requirements, local oversight in New York City is provided by institutional review boards (IRBs) at each participating research institution. These boards review and approve trial protocols to ensure they meet ethical standards and protect participant rights.
New York State also imposes additional regulations, managed by the New York State Department of Health, which oversees compliance with state-specific health and safety standards. Researchers must adhere to state laws regarding informed consent, data protection, and reporting of adverse events. Additionally, clinical trials conducted in the city must comply with the Health Insurance Portability and Accountability Act (HIPAA) to ensure the confidentiality of participant information.
Benefits of participating in clinical trials
Volunteering in a clinical trial gives participants the exclusive opportunity to experience innovative treatments and therapies before they become available to the broader public. Participants receive exceptional care from leading healthcare professionals who offer tailored support and meticulous monitoring throughout the study.
Participation in these trials is essential for driving forward medical research and can lead to major advancements in how conditions are treated and prevented. By joining a clinical trial, participants not only gain early access to pioneering medical solutions but also contribute significantly to the advancement of scientific understanding, paving the way for improved healthcare outcomes for future patients.
How to enroll in a clinical trial in New York City
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify your trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select your preferred location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore study details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the health profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.